It’s been 17 years since Dolly the sheep was cloned from a mammary cell. And now scientists applied the same technique to …
human embryonic stem cells
The new advance holds great promise for people with hearing loss, but scientists won’t know for years whether a similar treatment would really work in humans
Health authorities in the U.K. approved on Thursday Europe’s first clinical trial involving embryonic stem cells.
After a year of legal uncertainty, a federal judge ruled that U.S. taxpayer dollars can be used to support research on embryonic stem cells.
It’s been a good week for advocates of stem cell research, both politically and scientifically.
FDA Takes On Green Tea: Dr Pepper Snapple Group’s Canada Dry and Unilever’s Lipton are in hot water for overextended health claims on labels and promotional websites for their green tea products, reports the Los Angeles Times.